David Lamond
Director at Quince Therapeutics.
Raised on Quince Therapeutics filings
$114.7M
of $193.8M offered across 2 Form D filings
- Form D filings
- 2
- Teammates
- 6
- Last filing
- Jun 11, 2026
Company
Quince Therapeutics
Biotech · South San Francisco, CA
Drugs encapsulated in a patient's own red blood cells
Drugs encapsulated in a patient's own red blood cells
- Investors
- 27
- Still open
- $79.1M
Quince Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jun 11, 2026 | Equity | None sold/ $7.4M | Form D |
| Jun 11, 2026 | Equity | $114.7M/ $186.4M | Form D |
